nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2C19—Esomeprazole—Barrett's esophagus	0.162	0.261	CbGbCtD
Citalopram—CYP2C19—Omeprazole—Barrett's esophagus	0.0955	0.154	CbGbCtD
Citalopram—CYP1A2—Omeprazole—Barrett's esophagus	0.0881	0.142	CbGbCtD
Citalopram—CYP3A4—Esomeprazole—Barrett's esophagus	0.0783	0.126	CbGbCtD
Citalopram—ABCB1—Omeprazole—Barrett's esophagus	0.0771	0.124	CbGbCtD
Citalopram—CYP2D6—Omeprazole—Barrett's esophagus	0.0726	0.117	CbGbCtD
Citalopram—CYP3A4—Omeprazole—Barrett's esophagus	0.0462	0.0745	CbGbCtD
Citalopram—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.00481	0.135	CbGpPWpGaD
Citalopram—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00385	0.108	CbGpPWpGaD
Citalopram—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000972	0.0272	CbGpPWpGaD
Citalopram—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000757	0.0212	CbGpPWpGaD
Citalopram—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000757	0.0212	CbGpPWpGaD
Citalopram—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000741	0.0207	CbGpPWpGaD
Citalopram—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000741	0.0207	CbGpPWpGaD
Citalopram—CYP2E1—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.000614	0.0172	CbGpPWpGaD
Citalopram—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000599	0.0168	CbGpPWpGaD
Citalopram—Diplopia—Omeprazole—Barrett's esophagus	0.000577	0.00168	CcSEcCtD
Citalopram—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000577	0.00168	CcSEcCtD
Citalopram—Migraine—Omeprazole—Barrett's esophagus	0.000568	0.00165	CcSEcCtD
Citalopram—Migraine—Esomeprazole—Barrett's esophagus	0.000568	0.00165	CcSEcCtD
Citalopram—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000558	0.0156	CbGpPWpGaD
Citalopram—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000558	0.0156	CbGpPWpGaD
Citalopram—Face oedema—Omeprazole—Barrett's esophagus	0.000557	0.00162	CcSEcCtD
Citalopram—Face oedema—Esomeprazole—Barrett's esophagus	0.000557	0.00162	CcSEcCtD
Citalopram—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000554	0.0155	CbGpPWpGaD
Citalopram—Irritability—Esomeprazole—Barrett's esophagus	0.000551	0.0016	CcSEcCtD
Citalopram—Irritability—Omeprazole—Barrett's esophagus	0.000551	0.0016	CcSEcCtD
Citalopram—Dry skin—Omeprazole—Barrett's esophagus	0.000529	0.00154	CcSEcCtD
Citalopram—Dry skin—Esomeprazole—Barrett's esophagus	0.000529	0.00154	CcSEcCtD
Citalopram—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000527	0.00153	CcSEcCtD
Citalopram—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000527	0.00153	CcSEcCtD
Citalopram—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000525	0.00153	CcSEcCtD
Citalopram—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000525	0.00153	CcSEcCtD
Citalopram—Breast disorder—Omeprazole—Barrett's esophagus	0.000522	0.00151	CcSEcCtD
Citalopram—Breast disorder—Esomeprazole—Barrett's esophagus	0.000522	0.00151	CcSEcCtD
Citalopram—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00052	0.00151	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00052	0.00151	CcSEcCtD
Citalopram—Cramp muscle—Omeprazole—Barrett's esophagus	0.00052	0.00151	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00052	0.00151	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00052	0.00151	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00052	0.00151	CcSEcCtD
Citalopram—SLC6A4—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000513	0.0144	CbGpPWpGaD
Citalopram—Gastritis—Omeprazole—Barrett's esophagus	0.000511	0.00148	CcSEcCtD
Citalopram—Gastritis—Esomeprazole—Barrett's esophagus	0.000511	0.00148	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000509	0.00148	CcSEcCtD
Citalopram—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000509	0.00148	CcSEcCtD
Citalopram—Muscular weakness—Omeprazole—Barrett's esophagus	0.000509	0.00148	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000509	0.00148	CcSEcCtD
Citalopram—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000502	0.00146	CcSEcCtD
Citalopram—Abdominal distension—Omeprazole—Barrett's esophagus	0.000502	0.00146	CcSEcCtD
Citalopram—Influenza—Esomeprazole—Barrett's esophagus	0.000499	0.00145	CcSEcCtD
Citalopram—Dysphagia—Omeprazole—Barrett's esophagus	0.000499	0.00145	CcSEcCtD
Citalopram—Asthma—Omeprazole—Barrett's esophagus	0.000499	0.00145	CcSEcCtD
Citalopram—Dysphagia—Esomeprazole—Barrett's esophagus	0.000499	0.00145	CcSEcCtD
Citalopram—Influenza—Omeprazole—Barrett's esophagus	0.000499	0.00145	CcSEcCtD
Citalopram—Asthma—Esomeprazole—Barrett's esophagus	0.000499	0.00145	CcSEcCtD
Citalopram—Bronchospasm—Omeprazole—Barrett's esophagus	0.000491	0.00142	CcSEcCtD
Citalopram—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000491	0.00142	CcSEcCtD
Citalopram—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000489	0.00142	CcSEcCtD
Citalopram—Pancreatitis—Omeprazole—Barrett's esophagus	0.000489	0.00142	CcSEcCtD
Citalopram—Sweating increased—Esomeprazole—Barrett's esophagus	0.000486	0.00141	CcSEcCtD
Citalopram—Sweating increased—Omeprazole—Barrett's esophagus	0.000486	0.00141	CcSEcCtD
Citalopram—Angina pectoris—Omeprazole—Barrett's esophagus	0.000486	0.00141	CcSEcCtD
Citalopram—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000486	0.00141	CcSEcCtD
Citalopram—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00048	0.0134	CbGpPWpGaD
Citalopram—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000474	0.0133	CbGpPWpGaD
Citalopram—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000474	0.00138	CcSEcCtD
Citalopram—Pancytopenia—Omeprazole—Barrett's esophagus	0.000474	0.00138	CcSEcCtD
Citalopram—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000471	0.0132	CbGpPWpGaD
Citalopram—Dysuria—Omeprazole—Barrett's esophagus	0.000467	0.00135	CcSEcCtD
Citalopram—Dysuria—Esomeprazole—Barrett's esophagus	0.000467	0.00135	CcSEcCtD
Citalopram—CYP2E1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000464	0.013	CbGpPWpGaD
Citalopram—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000464	0.00135	CcSEcCtD
Citalopram—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000464	0.00135	CcSEcCtD
Citalopram—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000461	0.00134	CcSEcCtD
Citalopram—Pollakiuria—Omeprazole—Barrett's esophagus	0.000461	0.00134	CcSEcCtD
Citalopram—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00046	0.00133	CcSEcCtD
Citalopram—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00046	0.00133	CcSEcCtD
Citalopram—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000455	0.00132	CcSEcCtD
Citalopram—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000455	0.00132	CcSEcCtD
Citalopram—Weight increased—Omeprazole—Barrett's esophagus	0.000454	0.00132	CcSEcCtD
Citalopram—Weight increased—Esomeprazole—Barrett's esophagus	0.000454	0.00132	CcSEcCtD
Citalopram—Weight decreased—Omeprazole—Barrett's esophagus	0.000451	0.00131	CcSEcCtD
Citalopram—Weight decreased—Esomeprazole—Barrett's esophagus	0.000451	0.00131	CcSEcCtD
Citalopram—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000446	0.0125	CbGpPWpGaD
Citalopram—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000446	0.0125	CbGpPWpGaD
Citalopram—Infestation—Omeprazole—Barrett's esophagus	0.000445	0.00129	CcSEcCtD
Citalopram—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000445	0.00129	CcSEcCtD
Citalopram—Infestation—Esomeprazole—Barrett's esophagus	0.000445	0.00129	CcSEcCtD
Citalopram—Infestation NOS—Omeprazole—Barrett's esophagus	0.000445	0.00129	CcSEcCtD
Citalopram—Depression—Esomeprazole—Barrett's esophagus	0.000444	0.00129	CcSEcCtD
Citalopram—Depression—Omeprazole—Barrett's esophagus	0.000444	0.00129	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000441	0.00128	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000441	0.00128	CcSEcCtD
Citalopram—Stomatitis—Esomeprazole—Barrett's esophagus	0.000434	0.00126	CcSEcCtD
Citalopram—Stomatitis—Omeprazole—Barrett's esophagus	0.000434	0.00126	CcSEcCtD
Citalopram—Jaundice—Omeprazole—Barrett's esophagus	0.000434	0.00126	CcSEcCtD
Citalopram—Jaundice—Esomeprazole—Barrett's esophagus	0.000434	0.00126	CcSEcCtD
Citalopram—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000432	0.00126	CcSEcCtD
Citalopram—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000432	0.00126	CcSEcCtD
Citalopram—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000432	0.00126	CcSEcCtD
Citalopram—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000432	0.00126	CcSEcCtD
Citalopram—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000432	0.0121	CbGpPWpGaD
Citalopram—Haematuria—Omeprazole—Barrett's esophagus	0.000424	0.00123	CcSEcCtD
Citalopram—Haematuria—Esomeprazole—Barrett's esophagus	0.000424	0.00123	CcSEcCtD
Citalopram—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000421	0.00122	CcSEcCtD
Citalopram—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000421	0.00122	CcSEcCtD
Citalopram—Epistaxis—Esomeprazole—Barrett's esophagus	0.00042	0.00122	CcSEcCtD
Citalopram—Epistaxis—Omeprazole—Barrett's esophagus	0.00042	0.00122	CcSEcCtD
Citalopram—Sinusitis—Esomeprazole—Barrett's esophagus	0.000417	0.00121	CcSEcCtD
Citalopram—Sinusitis—Omeprazole—Barrett's esophagus	0.000417	0.00121	CcSEcCtD
Citalopram—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000415	0.00121	CcSEcCtD
Citalopram—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000415	0.00121	CcSEcCtD
Citalopram—Bradycardia—Omeprazole—Barrett's esophagus	0.000407	0.00118	CcSEcCtD
Citalopram—Bradycardia—Esomeprazole—Barrett's esophagus	0.000407	0.00118	CcSEcCtD
Citalopram—Rhinitis—Esomeprazole—Barrett's esophagus	0.0004	0.00116	CcSEcCtD
Citalopram—Rhinitis—Omeprazole—Barrett's esophagus	0.0004	0.00116	CcSEcCtD
Citalopram—Hepatitis—Omeprazole—Barrett's esophagus	0.000399	0.00116	CcSEcCtD
Citalopram—Hepatitis—Esomeprazole—Barrett's esophagus	0.000399	0.00116	CcSEcCtD
Citalopram—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000397	0.00115	CcSEcCtD
Citalopram—Hallucination—Omeprazole—Barrett's esophagus	0.000397	0.00115	CcSEcCtD
Citalopram—Hallucination—Esomeprazole—Barrett's esophagus	0.000397	0.00115	CcSEcCtD
Citalopram—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000397	0.00115	CcSEcCtD
Citalopram—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000396	0.00115	CcSEcCtD
Citalopram—Pharyngitis—Omeprazole—Barrett's esophagus	0.000396	0.00115	CcSEcCtD
Citalopram—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000394	0.00115	CcSEcCtD
Citalopram—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000394	0.00115	CcSEcCtD
Citalopram—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000393	0.00114	CcSEcCtD
Citalopram—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000393	0.00114	CcSEcCtD
Citalopram—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000392	0.00114	CcSEcCtD
Citalopram—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000392	0.00114	CcSEcCtD
Citalopram—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000392	0.00114	CcSEcCtD
Citalopram—Urethral disorder—Omeprazole—Barrett's esophagus	0.000392	0.00114	CcSEcCtD
Citalopram—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000389	0.0109	CbGpPWpGaD
Citalopram—Visual impairment—Omeprazole—Barrett's esophagus	0.000385	0.00112	CcSEcCtD
Citalopram—Visual impairment—Esomeprazole—Barrett's esophagus	0.000385	0.00112	CcSEcCtD
Citalopram—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000381	0.0107	CbGpPWpGaD
Citalopram—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000378	0.0011	CcSEcCtD
Citalopram—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000378	0.0011	CcSEcCtD
Citalopram—Eye disorder—Esomeprazole—Barrett's esophagus	0.000373	0.00108	CcSEcCtD
Citalopram—Eye disorder—Omeprazole—Barrett's esophagus	0.000373	0.00108	CcSEcCtD
Citalopram—Tinnitus—Esomeprazole—Barrett's esophagus	0.000372	0.00108	CcSEcCtD
Citalopram—Tinnitus—Omeprazole—Barrett's esophagus	0.000372	0.00108	CcSEcCtD
Citalopram—Flushing—Omeprazole—Barrett's esophagus	0.000371	0.00108	CcSEcCtD
Citalopram—Flushing—Esomeprazole—Barrett's esophagus	0.000371	0.00108	CcSEcCtD
Citalopram—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000363	0.0102	CbGpPWpGaD
Citalopram—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000361	0.00105	CcSEcCtD
Citalopram—Immune system disorder—Omeprazole—Barrett's esophagus	0.000361	0.00105	CcSEcCtD
Citalopram—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00036	0.00105	CcSEcCtD
Citalopram—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00036	0.00105	CcSEcCtD
Citalopram—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000359	0.01	CbGpPWpGaD
Citalopram—Chills—Omeprazole—Barrett's esophagus	0.000358	0.00104	CcSEcCtD
Citalopram—Chills—Esomeprazole—Barrett's esophagus	0.000358	0.00104	CcSEcCtD
Citalopram—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000358	0.01	CbGpPWpGaD
Citalopram—Alopecia—Omeprazole—Barrett's esophagus	0.000353	0.00102	CcSEcCtD
Citalopram—Alopecia—Esomeprazole—Barrett's esophagus	0.000353	0.00102	CcSEcCtD
Citalopram—Mental disorder—Esomeprazole—Barrett's esophagus	0.00035	0.00102	CcSEcCtD
Citalopram—Mental disorder—Omeprazole—Barrett's esophagus	0.00035	0.00102	CcSEcCtD
Citalopram—Malnutrition—Esomeprazole—Barrett's esophagus	0.000348	0.00101	CcSEcCtD
Citalopram—Malnutrition—Omeprazole—Barrett's esophagus	0.000348	0.00101	CcSEcCtD
Citalopram—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000344	0.00962	CbGpPWpGaD
Citalopram—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000344	0.00962	CbGpPWpGaD
Citalopram—Flatulence—Omeprazole—Barrett's esophagus	0.000343	0.000995	CcSEcCtD
Citalopram—Flatulence—Esomeprazole—Barrett's esophagus	0.000343	0.000995	CcSEcCtD
Citalopram—Tension—Omeprazole—Barrett's esophagus	0.000341	0.000991	CcSEcCtD
Citalopram—Tension—Esomeprazole—Barrett's esophagus	0.000341	0.000991	CcSEcCtD
Citalopram—Dysgeusia—Omeprazole—Barrett's esophagus	0.00034	0.000988	CcSEcCtD
Citalopram—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00034	0.000988	CcSEcCtD
Citalopram—Nervousness—Esomeprazole—Barrett's esophagus	0.000338	0.00098	CcSEcCtD
Citalopram—Nervousness—Omeprazole—Barrett's esophagus	0.000338	0.00098	CcSEcCtD
Citalopram—Back pain—Omeprazole—Barrett's esophagus	0.000336	0.000976	CcSEcCtD
Citalopram—Back pain—Esomeprazole—Barrett's esophagus	0.000336	0.000976	CcSEcCtD
Citalopram—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000334	0.00097	CcSEcCtD
Citalopram—Muscle spasms—Omeprazole—Barrett's esophagus	0.000334	0.00097	CcSEcCtD
Citalopram—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000334	0.00934	CbGpPWpGaD
Citalopram—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00033	0.00922	CbGpPWpGaD
Citalopram—Vision blurred—Omeprazole—Barrett's esophagus	0.000328	0.000951	CcSEcCtD
Citalopram—Vision blurred—Esomeprazole—Barrett's esophagus	0.000328	0.000951	CcSEcCtD
Citalopram—Tremor—Omeprazole—Barrett's esophagus	0.000326	0.000946	CcSEcCtD
Citalopram—Tremor—Esomeprazole—Barrett's esophagus	0.000326	0.000946	CcSEcCtD
Citalopram—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000323	0.000937	CcSEcCtD
Citalopram—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000323	0.000937	CcSEcCtD
Citalopram—Anaemia—Esomeprazole—Barrett's esophagus	0.000321	0.000933	CcSEcCtD
Citalopram—Anaemia—Omeprazole—Barrett's esophagus	0.000321	0.000933	CcSEcCtD
Citalopram—Agitation—Omeprazole—Barrett's esophagus	0.00032	0.000928	CcSEcCtD
Citalopram—Agitation—Esomeprazole—Barrett's esophagus	0.00032	0.000928	CcSEcCtD
Citalopram—Angioedema—Omeprazole—Barrett's esophagus	0.000318	0.000922	CcSEcCtD
Citalopram—Angioedema—Esomeprazole—Barrett's esophagus	0.000318	0.000922	CcSEcCtD
Citalopram—Malaise—Esomeprazole—Barrett's esophagus	0.000314	0.00091	CcSEcCtD
Citalopram—Malaise—Omeprazole—Barrett's esophagus	0.000314	0.00091	CcSEcCtD
Citalopram—Vertigo—Omeprazole—Barrett's esophagus	0.000312	0.000907	CcSEcCtD
Citalopram—Vertigo—Esomeprazole—Barrett's esophagus	0.000312	0.000907	CcSEcCtD
Citalopram—Leukopenia—Omeprazole—Barrett's esophagus	0.000311	0.000904	CcSEcCtD
Citalopram—Leukopenia—Esomeprazole—Barrett's esophagus	0.000311	0.000904	CcSEcCtD
Citalopram—Palpitations—Esomeprazole—Barrett's esophagus	0.000307	0.000892	CcSEcCtD
Citalopram—Palpitations—Omeprazole—Barrett's esophagus	0.000307	0.000892	CcSEcCtD
Citalopram—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000307	0.0086	CbGpPWpGaD
Citalopram—Cough—Omeprazole—Barrett's esophagus	0.000303	0.000881	CcSEcCtD
Citalopram—Cough—Esomeprazole—Barrett's esophagus	0.000303	0.000881	CcSEcCtD
Citalopram—Hypertension—Esomeprazole—Barrett's esophagus	0.0003	0.000871	CcSEcCtD
Citalopram—Hypertension—Omeprazole—Barrett's esophagus	0.0003	0.000871	CcSEcCtD
Citalopram—Myalgia—Omeprazole—Barrett's esophagus	0.000296	0.000859	CcSEcCtD
Citalopram—Arthralgia—Esomeprazole—Barrett's esophagus	0.000296	0.000859	CcSEcCtD
Citalopram—Arthralgia—Omeprazole—Barrett's esophagus	0.000296	0.000859	CcSEcCtD
Citalopram—Chest pain—Esomeprazole—Barrett's esophagus	0.000296	0.000859	CcSEcCtD
Citalopram—Chest pain—Omeprazole—Barrett's esophagus	0.000296	0.000859	CcSEcCtD
Citalopram—Myalgia—Esomeprazole—Barrett's esophagus	0.000296	0.000859	CcSEcCtD
Citalopram—Anxiety—Esomeprazole—Barrett's esophagus	0.000295	0.000856	CcSEcCtD
Citalopram—Anxiety—Omeprazole—Barrett's esophagus	0.000295	0.000856	CcSEcCtD
Citalopram—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000294	0.00824	CbGpPWpGaD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000294	0.000853	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000294	0.000853	CcSEcCtD
Citalopram—Discomfort—Omeprazole—Barrett's esophagus	0.000292	0.000849	CcSEcCtD
Citalopram—Discomfort—Esomeprazole—Barrett's esophagus	0.000292	0.000849	CcSEcCtD
Citalopram—Dry mouth—Esomeprazole—Barrett's esophagus	0.00029	0.00084	CcSEcCtD
Citalopram—Dry mouth—Omeprazole—Barrett's esophagus	0.00029	0.00084	CcSEcCtD
Citalopram—Confusional state—Omeprazole—Barrett's esophagus	0.000286	0.000831	CcSEcCtD
Citalopram—Confusional state—Esomeprazole—Barrett's esophagus	0.000286	0.000831	CcSEcCtD
Citalopram—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000284	0.000824	CcSEcCtD
Citalopram—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000284	0.000824	CcSEcCtD
Citalopram—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000283	0.00792	CbGpPWpGaD
Citalopram—Infection—Esomeprazole—Barrett's esophagus	0.000282	0.000818	CcSEcCtD
Citalopram—Infection—Omeprazole—Barrett's esophagus	0.000282	0.000818	CcSEcCtD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000281	0.00786	CbGpPWpGaD
Citalopram—Shock—Esomeprazole—Barrett's esophagus	0.000279	0.00081	CcSEcCtD
Citalopram—Shock—Omeprazole—Barrett's esophagus	0.000279	0.00081	CcSEcCtD
Citalopram—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000279	0.00781	CbGpPWpGaD
Citalopram—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000278	0.000808	CcSEcCtD
Citalopram—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000278	0.000808	CcSEcCtD
Citalopram—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000278	0.000807	CcSEcCtD
Citalopram—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000278	0.000807	CcSEcCtD
Citalopram—Tachycardia—Esomeprazole—Barrett's esophagus	0.000277	0.000804	CcSEcCtD
Citalopram—Tachycardia—Omeprazole—Barrett's esophagus	0.000277	0.000804	CcSEcCtD
Citalopram—Skin disorder—Omeprazole—Barrett's esophagus	0.000276	0.0008	CcSEcCtD
Citalopram—Skin disorder—Esomeprazole—Barrett's esophagus	0.000276	0.0008	CcSEcCtD
Citalopram—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000274	0.000796	CcSEcCtD
Citalopram—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000274	0.000796	CcSEcCtD
Citalopram—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000271	0.00757	CbGpPWpGaD
Citalopram—Anorexia—Omeprazole—Barrett's esophagus	0.00027	0.000785	CcSEcCtD
Citalopram—Anorexia—Esomeprazole—Barrett's esophagus	0.00027	0.000785	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000259	0.000751	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000259	0.000751	CcSEcCtD
Citalopram—Insomnia—Esomeprazole—Barrett's esophagus	0.000257	0.000745	CcSEcCtD
Citalopram—Insomnia—Omeprazole—Barrett's esophagus	0.000257	0.000745	CcSEcCtD
Citalopram—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000255	0.00074	CcSEcCtD
Citalopram—Paraesthesia—Omeprazole—Barrett's esophagus	0.000255	0.00074	CcSEcCtD
Citalopram—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000253	0.000734	CcSEcCtD
Citalopram—Dyspnoea—Omeprazole—Barrett's esophagus	0.000253	0.000734	CcSEcCtD
Citalopram—Somnolence—Esomeprazole—Barrett's esophagus	0.000252	0.000732	CcSEcCtD
Citalopram—Somnolence—Omeprazole—Barrett's esophagus	0.000252	0.000732	CcSEcCtD
Citalopram—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00025	0.000725	CcSEcCtD
Citalopram—Dyspepsia—Omeprazole—Barrett's esophagus	0.00025	0.000725	CcSEcCtD
Citalopram—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000249	0.00697	CbGpPWpGaD
Citalopram—Decreased appetite—Omeprazole—Barrett's esophagus	0.000247	0.000716	CcSEcCtD
Citalopram—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000247	0.000716	CcSEcCtD
Citalopram—HTR2C—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000246	0.00687	CbGpPWpGaD
Citalopram—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000245	0.000711	CcSEcCtD
Citalopram—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000245	0.000711	CcSEcCtD
Citalopram—Fatigue—Omeprazole—Barrett's esophagus	0.000245	0.00071	CcSEcCtD
Citalopram—Fatigue—Esomeprazole—Barrett's esophagus	0.000245	0.00071	CcSEcCtD
Citalopram—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000244	0.00682	CbGpPWpGaD
Citalopram—Pain—Omeprazole—Barrett's esophagus	0.000243	0.000704	CcSEcCtD
Citalopram—Constipation—Omeprazole—Barrett's esophagus	0.000243	0.000704	CcSEcCtD
Citalopram—Constipation—Esomeprazole—Barrett's esophagus	0.000243	0.000704	CcSEcCtD
Citalopram—Pain—Esomeprazole—Barrett's esophagus	0.000243	0.000704	CcSEcCtD
Citalopram—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000238	0.00667	CbGpPWpGaD
Citalopram—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000234	0.000679	CcSEcCtD
Citalopram—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000234	0.000679	CcSEcCtD
Citalopram—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000232	0.000674	CcSEcCtD
Citalopram—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000232	0.000674	CcSEcCtD
Citalopram—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000229	0.00642	CbGpPWpGaD
Citalopram—Urticaria—Omeprazole—Barrett's esophagus	0.000225	0.000654	CcSEcCtD
Citalopram—Urticaria—Esomeprazole—Barrett's esophagus	0.000225	0.000654	CcSEcCtD
Citalopram—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000224	0.000651	CcSEcCtD
Citalopram—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000224	0.000651	CcSEcCtD
Citalopram—Abdominal pain—Omeprazole—Barrett's esophagus	0.000224	0.000651	CcSEcCtD
Citalopram—Body temperature increased—Omeprazole—Barrett's esophagus	0.000224	0.000651	CcSEcCtD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00022	0.00615	CbGpPWpGaD
Citalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000218	0.00611	CbGpPWpGaD
Citalopram—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000215	0.00603	CbGpPWpGaD
Citalopram—HRH1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000213	0.00596	CbGpPWpGaD
Citalopram—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000212	0.00594	CbGpPWpGaD
Citalopram—SLC6A4—NRF2 pathway—HGF—Barrett's esophagus	0.000211	0.0059	CbGpPWpGaD
Citalopram—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000209	0.000607	CcSEcCtD
Citalopram—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000209	0.000607	CcSEcCtD
Citalopram—ADRA1A—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000209	0.00584	CbGpPWpGaD
Citalopram—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000207	0.00579	CbGpPWpGaD
Citalopram—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000204	0.00571	CbGpPWpGaD
Citalopram—Asthenia—Omeprazole—Barrett's esophagus	0.000204	0.000591	CcSEcCtD
Citalopram—Asthenia—Esomeprazole—Barrett's esophagus	0.000204	0.000591	CcSEcCtD
Citalopram—CYP2E1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000203	0.00567	CbGpPWpGaD
Citalopram—Pruritus—Esomeprazole—Barrett's esophagus	0.000201	0.000583	CcSEcCtD
Citalopram—Pruritus—Omeprazole—Barrett's esophagus	0.000201	0.000583	CcSEcCtD
Citalopram—CYP2E1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.0002	0.00559	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000195	0.00546	CbGpPWpGaD
Citalopram—Diarrhoea—Omeprazole—Barrett's esophagus	0.000194	0.000564	CcSEcCtD
Citalopram—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000194	0.000564	CcSEcCtD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00019	0.00533	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00019	0.00531	CbGpPWpGaD
Citalopram—Dizziness—Esomeprazole—Barrett's esophagus	0.000188	0.000545	CcSEcCtD
Citalopram—Dizziness—Omeprazole—Barrett's esophagus	0.000188	0.000545	CcSEcCtD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000187	0.00523	CbGpPWpGaD
Citalopram—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000184	0.00514	CbGpPWpGaD
Citalopram—SLC6A2—NRF2 pathway—HGF—Barrett's esophagus	0.000181	0.00508	CbGpPWpGaD
Citalopram—Vomiting—Omeprazole—Barrett's esophagus	0.00018	0.000524	CcSEcCtD
Citalopram—Vomiting—Esomeprazole—Barrett's esophagus	0.00018	0.000524	CcSEcCtD
Citalopram—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000179	0.00502	CbGpPWpGaD
Citalopram—Rash—Esomeprazole—Barrett's esophagus	0.000179	0.000519	CcSEcCtD
Citalopram—Rash—Omeprazole—Barrett's esophagus	0.000179	0.000519	CcSEcCtD
Citalopram—Dermatitis—Omeprazole—Barrett's esophagus	0.000179	0.000519	CcSEcCtD
Citalopram—Dermatitis—Esomeprazole—Barrett's esophagus	0.000179	0.000519	CcSEcCtD
Citalopram—Headache—Omeprazole—Barrett's esophagus	0.000178	0.000516	CcSEcCtD
Citalopram—Headache—Esomeprazole—Barrett's esophagus	0.000178	0.000516	CcSEcCtD
Citalopram—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000177	0.00495	CbGpPWpGaD
Citalopram—Nausea—Omeprazole—Barrett's esophagus	0.000169	0.000489	CcSEcCtD
Citalopram—Nausea—Esomeprazole—Barrett's esophagus	0.000169	0.000489	CcSEcCtD
Citalopram—HRH1—IL-4 Signaling Pathway—RELA—Barrett's esophagus	0.000163	0.00456	CbGpPWpGaD
Citalopram—SLC6A3—NRF2 pathway—HGF—Barrett's esophagus	0.000161	0.0045	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000159	0.00445	CbGpPWpGaD
Citalopram—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000156	0.00437	CbGpPWpGaD
Citalopram—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000154	0.00431	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000149	0.00416	CbGpPWpGaD
Citalopram—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000147	0.0041	CbGpPWpGaD
Citalopram—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000144	0.00402	CbGpPWpGaD
Citalopram—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000142	0.00397	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000132	0.00369	CbGpPWpGaD
Citalopram—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000122	0.00341	CbGpPWpGaD
Citalopram—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00012	0.00336	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000117	0.00328	CbGpPWpGaD
Citalopram—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000113	0.00317	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000111	0.00312	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000109	0.00306	CbGpPWpGaD
Citalopram—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000109	0.00304	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	9.66e-05	0.0027	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	9.63e-05	0.00269	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	9.48e-05	0.00265	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.4e-05	0.00263	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	9.32e-05	0.00261	CbGpPWpGaD
Citalopram—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.27e-05	0.00259	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	9.23e-05	0.00258	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.12e-05	0.00255	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	9.06e-05	0.00253	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—SST—Barrett's esophagus	8.49e-05	0.00238	CbGpPWpGaD
Citalopram—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.47e-05	0.00237	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	8.08e-05	0.00226	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.92e-05	0.00222	CbGpPWpGaD
Citalopram—ADRA1A—AMPK Signaling—TP53—Barrett's esophagus	7.6e-05	0.00213	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—SST—Barrett's esophagus	7.36e-05	0.00206	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	7.33e-05	0.00205	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—SST—Barrett's esophagus	7.22e-05	0.00202	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	7.14e-05	0.002	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	7.01e-05	0.00196	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—GAST—Barrett's esophagus	7e-05	0.00196	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.55e-05	0.00183	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—GAST—Barrett's esophagus	6.36e-05	0.00178	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.17e-05	0.00173	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—GAST—Barrett's esophagus	6.07e-05	0.0017	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	6.05e-05	0.00169	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—GAST—Barrett's esophagus	5.95e-05	0.00167	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—GAST—Barrett's esophagus	5.51e-05	0.00154	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	5.49e-05	0.00154	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—TP53—Barrett's esophagus	5.48e-05	0.00153	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—GAST—Barrett's esophagus	5.41e-05	0.00151	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—SST—Barrett's esophagus	4.8e-05	0.00134	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.78e-05	0.00134	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGES—Barrett's esophagus	4.67e-05	0.00131	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGES—Barrett's esophagus	4.57e-05	0.00128	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—SST—Barrett's esophagus	4.36e-05	0.00122	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.34e-05	0.00122	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—SST—Barrett's esophagus	4.16e-05	0.00116	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	4.14e-05	0.00116	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—SST—Barrett's esophagus	4.08e-05	0.00114	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.02e-05	0.00112	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—SST—Barrett's esophagus	3.78e-05	0.00106	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.76e-05	0.00105	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	3.76e-05	0.00105	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GAST—Barrett's esophagus	3.76e-05	0.00105	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.75e-05	0.00105	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—SST—Barrett's esophagus	3.7e-05	0.00104	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.69e-05	0.00103	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.63e-05	0.00102	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	3.54e-05	0.00099	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.53e-05	0.000987	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	3.47e-05	0.00097	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.44e-05	0.000963	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCL8—Barrett's esophagus	3.31e-05	0.000926	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	3.28e-05	0.000918	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GAST—Barrett's esophagus	3.25e-05	0.000911	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.24e-05	0.000908	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	3.24e-05	0.000908	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GAST—Barrett's esophagus	3.19e-05	0.000893	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCL8—Barrett's esophagus	2.87e-05	0.000802	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	2.86e-05	0.000799	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCL8—Barrett's esophagus	2.81e-05	0.000787	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.75e-05	0.000769	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.67e-05	0.000748	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.61e-05	0.00073	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SST—Barrett's esophagus	2.57e-05	0.00072	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.55e-05	0.000714	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	2.5e-05	0.000699	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.46e-05	0.000688	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SST—Barrett's esophagus	2.23e-05	0.000624	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SST—Barrett's esophagus	2.22e-05	0.000622	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SST—Barrett's esophagus	2.19e-05	0.000612	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.16e-05	0.000605	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.12e-05	0.000594	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.08e-05	0.000583	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.98e-05	0.000553	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.93e-05	0.000539	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.88e-05	0.000526	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.87e-05	0.000523	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.77e-05	0.000496	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL8—Barrett's esophagus	1.7e-05	0.000475	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.62e-05	0.000453	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.61e-05	0.000452	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.61e-05	0.00045	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.59e-05	0.000445	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.55e-05	0.000435	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.54e-05	0.000431	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.5e-05	0.00042	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.47e-05	0.000412	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.47e-05	0.00041	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL8—Barrett's esophagus	1.44e-05	0.000404	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APC—Barrett's esophagus	1.36e-05	0.000381	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.21e-05	0.000339	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APC—Barrett's esophagus	1.18e-05	0.00033	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.18e-05	0.000329	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARG—Barrett's esophagus	1.16e-05	0.000326	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.16e-05	0.000324	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APC—Barrett's esophagus	1.16e-05	0.000324	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARG—Barrett's esophagus	1.14e-05	0.000319	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RELA—Barrett's esophagus	1.06e-05	0.000298	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL8—Barrett's esophagus	1e-05	0.000281	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RELA—Barrett's esophagus	9.22e-06	0.000258	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	9.19e-06	0.000257	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	9.16e-06	0.000256	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RELA—Barrett's esophagus	9.05e-06	0.000253	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	8.97e-06	0.000251	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARG—Barrett's esophagus	8.8e-06	0.000246	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL8—Barrett's esophagus	8.69e-06	0.000243	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	8.66e-06	0.000242	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARG—Barrett's esophagus	8.59e-06	0.00024	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL8—Barrett's esophagus	8.53e-06	0.000239	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.09e-06	0.000226	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	6.92e-06	0.000194	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARG—Barrett's esophagus	6.85e-06	0.000192	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—Barrett's esophagus	6.75e-06	0.000189	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	6.37e-06	0.000178	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—Barrett's esophagus	6.15e-06	0.000172	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	5.39e-06	0.000151	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—Barrett's esophagus	5.33e-06	0.000149	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	5.31e-06	0.000149	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.29e-06	0.000148	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—Barrett's esophagus	5.23e-06	0.000146	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.16e-06	0.000116	CbGpPWpGaD
